Under the 503A pathway, the bulk substance must be a component of an FDA-approved drug, appear in a USP or NF monograph, or sit on the FDA-evaluated 503A bulk drug substances list
Frequently Asked Questions Can I use GLP-1 medication if I have a normal BMI but high insulin levels
Importantly, tirzepatide may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying
Clinical trials have revealed that when administered in higher doses than those used for diabetes treatment, Semaglutide leads to significant and sustained weight loss in individuals with obesity
Novo Nordisk Patient Assistance Program (PAP), NovoCare Diabetes (n.d.) Novo Nordisk Patient Assistance Program Application, Novo Nordisk (n.d.) Human drug compounding, U.S
Coverage may also apply if your BMI is 27 or above alongside a weight-related condition such as type 2 diabetes or high blood pressure